Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.33 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.33 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26013136 | 0.89 | NPC1 (0.33) | NPC1CASP3RAB9ASMN1; SMN2SENP8 | |
| SCHEMBL26014765 | 0.84 | NPC1 (0.30) | NPC1CASP3RAB9ASENP8SENP7 | |
| SCHEMBL26014716 | 0.84 | CA1 (0.30) | NPC1RAB9A | |
| SCHEMBL26014674 | 0.84 | — | — | |
| SCHEMBL26014712 | 0.83 | — | — | |
| SCHEMBL25445946 | 0.83 | GABRA1 (0.34) | NPC1CASP3RAB9ASMN1; SMN2SENP8 | |
| SCHEMBL25445955 | 0.83 | GABRA1 (0.34) | NPC1CASP3RAB9ASMN1; SMN2SENP8 | |
| SCHEMBL26014238 | 0.83 | NPC1 (0.38) | NPC1CASP3RAB9ASMN1; SMN2SENP8 | |
| SCHEMBL26014675 | 0.81 | LMNA (0.41) | — | |
| SCHEMBL25884873 | 0.80 | GABRA1 (0.34) | NPC1CASP3RAB9ASMN1; SMN2SENP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713333-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713333-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | ORC3, LAGE3, ORMDL3 | NPC1 2512/4885CASP3 3604/4885RAB9A 3590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.